---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "v8o9H7DGx+l5tTvK4LE6KFHEzLRa6kmirNbmUchjYT/rzX1+NRMQyPx6WCRSVqcs60AKXtlkbQvcDM1ozAdA1E9v66PERvCc78Jt0sU8QStAeiHXT38zM2mxRNtS1Wy3NTG+eBLxswA7jg/AuseO9oCHbdRrcJlJ8IjIznEWq6lVTJWZRyqEH/wcHadss35dRqpQd5AN/uAozrgE9w0s8LGChHUPwy42Yeit8wuHH9y3/jAeMVBtfX5gHoQar2zAM2V4Lc85ZspEMw/BYM+IwIo1sbzdfMiFZVSVxvP1r01RvyDsJvAirAN9R0bZmh6NxVBiOrrkg6NHEjYxiYwFbnJHc9YQmvDAu8YjyKAYrTo=;aD7WPtf4Yfo8vsLc9l2twA=="
---

